Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-13 | 2,998,908 | $0.06 | $179.93kSell |
Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-12 | 1,614,541 | $0.07 | $113.02kSell |
Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-11 | 1,343,801 | $0.08 | $107.50kSell |
Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-10 | 1,570,947 | $0.09 | $141.39kSell |
Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-09 | 850,543 | $0.11 | $93.56kSell |
Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-12-06 | 1,236,874 | $0.12 | $148.42kSell |
Yk Bioventures Opportunities GP I LLC | 10% Owner | 2024-10-10 | 3,250,000 | $0.10 | $325.00kSell |
Stuart M. Sloan | 10% Owner | 2024-09-25 | 532,486 | $0.10 | $55.38kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Stuart M. Sloan | 401.44% | 21,600,442 | $15.12M | Insider |
Brian G. Atwood | 373.54% | 20,099,097 | $14.07M | Insider |
Yk Bioventures Opportunities GP I LLC | 241.70% | 13,005,169 | $9.10M | Insider |
Arch Venture Management LLC | 174.58% | 9,393,561 | $6.58M | Institution |
Christopher B. Ehrlich | 126.29% | 6,795,408 | $4.76M | Insider |
Avantax Planning Partners Inc | 48.04% | 2,585,151 | $1.81M | Institution |
Shami Patel | 20.82% | 1,120,254 | $784.18k | Insider |
Phoenix Biotech Sponsor LLC | 18.58% | 1,000,000 | $700.00k | Insider |
Kathleen Laporte | 18.06% | 971,825 | $680.28k | Insider |
Cubist Systematic Strategies LLC | 6.20% | 333,442 | $233.41k | Institution |